WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Dormant
DIN Number
02453703
Drug Class
Human
Market Date
Dec 23, 2016
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02453703
AIG Number0311391002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.92
Health Canada Classification
ACTIVE INGREDIENTS (3)
ACETAMINOPHENActive
Strength: 300 MG
Monograph: ACETAMINOPHEN
CAFFEINEActive
Strength: 15 MG
Monograph: CAFFEINE
CODEINE PHOSPHATEActive
Strength: 8 MG
Monograph: CODEINE PHOSPHATE